John Simard

3.8k total citations · 1 hit paper
24 papers, 3.0k citations indexed

About

John Simard is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, John Simard has authored 24 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in John Simard's work include Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (7 papers) and T-cell and B-cell Immunology (5 papers). John Simard is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (7 papers) and T-cell and B-cell Immunology (5 papers). John Simard collaborates with scholars based in United States, Canada and Switzerland. John Simard's co-authors include Thomas M. Kündig, Pamela S. Ohashi, Andrew Wakeham, Rudolf Schmits, Tak W. Mak, Caren Furlonger, Christopher J. Paige, T. Matsuyama, Henrik Griesser and Emma Timms and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

John Simard

24 papers receiving 3.0k citations

Hit Papers

Deregulated T Cell Activation and Autoimmunity in Mice La... 1995 2026 2005 2015 1995 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Deregulated T Cell Activation and Autoimmunity in Mice Lacking Interleukin-2 Receptor β
    1995 727 citations Haruhiko Suzuki, Thomas M. Kündig et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Simard United States 17 1.9k 684 548 491 321 24 3.0k
Toshiyuki Hori Japan 31 2.4k 1.3× 628 0.9× 974 1.8× 636 1.3× 696 2.2× 75 3.8k
Omar Duramad United States 14 2.3k 1.2× 605 0.9× 300 0.5× 431 0.9× 537 1.7× 19 3.2k
Sara Trifari United States 17 2.8k 1.5× 593 0.9× 590 1.1× 361 0.7× 451 1.4× 21 3.7k
Nobuo Kanazawa Japan 27 1.6k 0.8× 1.1k 1.6× 559 1.0× 151 0.3× 473 1.5× 131 3.5k
Laura Bover United States 26 2.3k 1.2× 936 1.4× 926 1.7× 228 0.5× 213 0.7× 58 3.7k
Jonathan C. Poe United States 37 4.2k 2.3× 917 1.3× 855 1.6× 334 0.7× 207 0.6× 62 5.8k
Morio Nagira Japan 17 1.9k 1.0× 476 0.7× 1.5k 2.7× 419 0.9× 334 1.0× 29 3.3k
Smina Aït‐Yahia France 21 4.0k 2.2× 847 1.2× 1.3k 2.3× 317 0.6× 320 1.0× 22 5.0k
Patrice Douillard France 25 2.0k 1.1× 734 1.1× 351 0.6× 186 0.4× 99 0.3× 43 2.8k
Brian M. Macduff Canada 11 2.4k 1.3× 412 0.6× 553 1.0× 247 0.5× 212 0.7× 11 3.1k

Countries citing papers authored by John Simard

Since Specialization
Citations

This map shows the geographic impact of John Simard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Simard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Simard more than expected).

Fields of papers citing papers by John Simard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Simard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Simard. The network helps show where John Simard may publish in the future.

Co-authorship network of co-authors of John Simard

This figure shows the co-authorship network connecting the top 25 collaborators of John Simard. A scholar is included among the top collaborators of John Simard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Simard. John Simard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thibaudin, Marion, Antonin Schmitt, Leila Bengrine, et al.. (2025). Safety and efficacy of trifluridine/tipiracil +/− bevacizumab plus XB2001 (anti-IL-1α antibody): a single-center phase 1 trial. Signal Transduction and Targeted Therapy. 10(1). 22–22. 1 indexed citations
2.
Renieris, Georgios, Eleni Karakike, Theologia Gkavogianni, et al.. (2022). IL-1 Mediates Tissue-Specific Inflammation and Severe Respiratory Failure in COVID-19. Journal of Innate Immunity. 14(6). 643–656. 20 indexed citations
3.
Gottlieb, Alice B., Francisco A. Kerdel, Seth Forman, et al.. (2020). A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain. Journal of Investigative Dermatology. 140(8). 1538–1545.e2. 64 indexed citations
4.
Varshney, Avanish K., Jian Lin, Yanfeng Zhang, et al.. (2018). A natural human monoclonal antibody targeting Staphylococcus Protein A protects against Staphylococcus aureus bacteremia. PLoS ONE. 13(1). e0190537–e0190537. 62 indexed citations
5.
6.
7.
Hickish, Tamas, Thierry André, Lucjan Wyrwicz, et al.. (2017). MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study. The Lancet Oncology. 18(2). 192–201. 121 indexed citations
8.
Kanni, Theodora, Themistoklis Spyridopoulos, Aikaterini Pistiki, et al.. (2017). MABp1 Targeting IL-1α for Moderate to Severe Hidradenitis Suppurativa Not Eligible for Adalimumab: A Randomized Study. Journal of Investigative Dermatology. 138(4). 795–801. 83 indexed citations
9.
Hong, David S., Filip Jankú, Aung Naing, et al.. (2015). Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer. Investigational New Drugs. 33(3). 621–631. 55 indexed citations
10.
Hong, David S., David Hui, Éduardo Bruera, et al.. (2014). MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study. The Lancet Oncology. 15(6). 656–666. 162 indexed citations
11.
Clark, Matthew, et al.. (2012). The Airplane Game: Lean Accounting Takes Flight. Management accounting quarterly. 14(1). 1. 3 indexed citations
12.
Hong, David S., Aung Naing, Gerald S. Falchook, et al.. (2011). Abstract A211: A phase I study of MABp1, a first-in-human, first-true human monoclonal antibody against the IL-1 in patients with advanced cancers.. Molecular Cancer Therapeutics. 10(11_Supplement). A211–A211. 4 indexed citations
13.
Senti, Gabriela, Bettina M. Prinz Vavricka, Richárd Márkus, et al.. (2008). Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial. Proceedings of the National Academy of Sciences. 105(46). 17908–17912. 254 indexed citations
14.
Johansen, Pål, Andreas C. Häffner, Karoline Zepter, et al.. (2005). Direct intralymphatic injection of peptide vaccines enhances immunogenicity. European Journal of Immunology. 35(2). 568–574. 106 indexed citations
15.
Mak, Tak W. & John Simard. (1998). Handbook of Immune Response Genes. 11 indexed citations
16.
Schmits, Rudolf, Thomas M. Kündig, John Simard, et al.. (1996). LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor.. The Journal of Experimental Medicine. 183(4). 1415–1426. 226 indexed citations
17.
Amakawa, Ryuichi, Anne Hakem, Thomas M. Kündig, et al.. (1996). Impaired Negative Selection of T Cells in Hodgkin's Disease Antigen CD30–Deficient Mice. Cell. 84(4). 551–562. 266 indexed citations
18.
Kündig, Thomas M., M F Bachmann, S Oehen, et al.. (1996). On the role of antigen in maintaining cytotoxic T-cell memory.. Proceedings of the National Academy of Sciences. 93(18). 9716–9723. 198 indexed citations
19.
Suzuki, Haruhiko, Thomas M. Kündig, Caren Furlonger, et al.. (1995). Deregulated T Cell Activation and Autoimmunity in Mice Lacking Interleukin-2 Receptor β. Science. 268(5216). 1472–1476. 727 indexed citations breakdown →
20.
Higgins, Robert, et al.. (1994). Evaluation of the antibody response in pigs vaccinated against Streptococcus suis capsular type 2 using a double-antibody sandwich enzyme-linked immunosorbent assay.. PubMed. 58(1). 49–54. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshiyuki Hori Breakdown of academic impact, for papers by Omar Duramad Breakdown of academic impact, for papers by Sara Trifari Breakdown of academic impact, for papers by Nobuo Kanazawa Breakdown of academic impact, for papers by Laura Bover Breakdown of academic impact, for papers by Jonathan C. Poe Breakdown of academic impact, for papers by Morio Nagira Breakdown of academic impact, for papers by Smina Aït‐Yahia Breakdown of academic impact, for papers by Patrice Douillard Breakdown of academic impact, for papers by Brian M. Macduff
Rankless by CCL
2026